Infective endocarditis is an uncommon disease but still carries high morbidity and mortality. The management of the patient with infective endocarditis changed over the last years with improvement of diagnostic tools and early aggressive medical and surgical treatment. The multidisciplinary approach is an accepted standard of practice and approximately 40-50% of patients discussed in endocarditis teams undergoes surgery. Timing of surgery remains a debated issue, while complexity of surgery remains a characteristic of this pathology. Although isolated native valve endocarditis remains associated with acceptable morbidity and mortality, the same still high in the setting of multiple valve surgery and prosthetic infections.